antipsychotics

Eyles, E., Margelyte, R., Edwards, H. B., Moran, P. A., Kessler, D. S., Davies, S. J. C., et al. (2023). Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink. Schizophr Bull. http://doi.org/10.1093/schbul/sbad126
Domzaridou, E., Carr, M. J., Millar, T., Webb, R. T., & Ashcroft, D. M. (2023). Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records. Addiction. http://doi.org/10.1111/add.16306
Tran, C. T., Bøg, M., Collings, S. L., Johnson, M., Qizilbash, N., Lind, S., et al. (2022). Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink. Curr Med Res Opin, 1-8. http://doi.org/10.1080/03007995.2022.2029381